AU1197001A - B cell clonal toxins and methods for using the same - Google Patents

B cell clonal toxins and methods for using the same

Info

Publication number
AU1197001A
AU1197001A AU11970/01A AU1197001A AU1197001A AU 1197001 A AU1197001 A AU 1197001A AU 11970/01 A AU11970/01 A AU 11970/01A AU 1197001 A AU1197001 A AU 1197001A AU 1197001 A AU1197001 A AU 1197001A
Authority
AU
Australia
Prior art keywords
toxins
methods
same
cell clonal
clonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11970/01A
Inventor
Jay W. Chaplin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUTE FOR APPLIED BIOMEDICINE
Original Assignee
INST APPLIED BIOMEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST APPLIED BIOMEDICINE filed Critical INST APPLIED BIOMEDICINE
Publication of AU1197001A publication Critical patent/AU1197001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU11970/01A 1999-10-29 2000-10-12 B cell clonal toxins and methods for using the same Abandoned AU1197001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16246499P 1999-10-29 1999-10-29
US60162464 1999-10-29
PCT/US2000/028157 WO2001032853A1 (en) 1999-10-29 2000-10-12 B cell clonal toxins and methods for using the same

Publications (1)

Publication Number Publication Date
AU1197001A true AU1197001A (en) 2001-05-14

Family

ID=22585734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11970/01A Abandoned AU1197001A (en) 1999-10-29 2000-10-12 B cell clonal toxins and methods for using the same

Country Status (2)

Country Link
AU (1) AU1197001A (en)
WO (1) WO2001032853A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041560A1 (en) * 2000-08-24 2002-03-07 Max Delbrueck Centrum New peptide from the alpha1 adrenergic receptor, useful for diagnosis and treatment of psoriasis, and also for raising specific antibodies
EP1478659B1 (en) * 2001-07-13 2008-11-12 CMS Peptides Patent Holding Company Limited Biologically active peptides
EP1419173B1 (en) * 2001-08-10 2008-11-26 Novartis AG Peptides that bind to atherosclerotic lesions
WO2005051291A2 (en) * 2003-11-14 2005-06-09 Chaplin Jay W B-cell-targeted toxin for immuno response reduction
WO2012107932A1 (en) * 2011-02-11 2012-08-16 Transgene Biotek Ltd. B cell clonal immunotoxin and use thereof
CN109467599B (en) * 2017-09-08 2021-06-04 武汉华纪元生物技术开发有限公司 Short peptide ATR001, monoclonal antibody prepared from short peptide and having function of preferentially regulating AT1R, and application of monoclonal antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831142A (en) * 1994-01-07 1998-11-03 Dana Farber Cancer Institute, Inc. Regulatory elements controlling tissue-specific gene expression

Also Published As

Publication number Publication date
WO2001032853A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU2001292539A1 (en) Fuel cell assembly and method for making the same
AU1290001A (en) Antibodies
AU6864600A (en) Fuel cell
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2736101A (en) Transporters and ion channels
AU4935000A (en) Antibodies
AU6136499A (en) Injector, methods for using injector, and kit
AU2001249466A1 (en) System and methods for designing group retirement plans
AU6955100A (en) Battery
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU5043600A (en) Battery
AU3360600A (en) Content certification
AU1106401A (en) Battery
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU5171600A (en) Battery
AU2001293118A1 (en) Dosimeter and method for using the same
AU7849200A (en) Mannosidases and methods for using same
AU4625100A (en) Stable catalysts and processes for making and using the same
AU1083501A (en) Antibiotic-metal complex and methods
AU4312101A (en) Secure delivery receptacle and method for using the same
AU1197001A (en) B cell clonal toxins and methods for using the same
EP1170811A3 (en) Fuel cell system and method for operating the system
AU7641898A (en) Ion paris, method for the production and use thereof as contrast agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase